Cargando…
Red Blood Cell Extracellular Vesicle-Based Drug Delivery: Challenges and Opportunities
Recently, red blood cell-derived extracellular vesicles (RBCEVs) have attracted attention for clinical applications because of their safety and biocompatibility. RBCEVs can escape macrophages through the binding of CD47 to inhibitory receptor signal regulatory protein α. Furthermore, genetic materia...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739511/ https://www.ncbi.nlm.nih.gov/pubmed/35004730 http://dx.doi.org/10.3389/fmed.2021.761362 |